Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Published clinical research has characterised the compound in controlled trials: a Phase 2 obesity trial reported dose-dependent body-weight change in the study population (Jastreboff et al., 2023), and a separate Phase 2 trial investigated the GIP/GLP-1/glucagon agonist in people with type 2 diabetes (Rosenstock et al., 2023)
It is recommended to consult a doctor before during pregnancy or breastfeeding
Context Community low-dose context Dose 500 mcg to 1 mg Notes Reported by users seeking sexual-function effects with less GI burden
Understanding how peptides interact with other treatments is essential for avoiding complications and maximizing benefits
See what's included in each Success by Sesame plan Success by Sesame Pricing: Program Fees vs
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
